Bellevue Group Ag has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $5.93 Billion distributed in 196 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $343M, Ionis Pharmaceuticals Inc with a value of $315M, Vertex Pharmaceuticals Inc with a value of $266M, Intuitive Surgical Inc with a value of $244M, and Alnylam Pharmaceuticals, Inc. with a value of $223M.

Examining the 13F form we can see an decrease of $42.8M in the current position value, from $5.98B to 5.93B.

Bellevue Group Ag is based out at Kuesnacht, V8

Below you can find more details about Bellevue Group Ag portfolio as well as his latest detailed transactions.

Portfolio value $5.93 Billion
Healthcare: $5.93 Billion
Communication Services: $1.21 Million
Technology: $531,000
Consumer Cyclical: $309,000

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 196
  • Current Value $5.93 Billion
  • Prior Value $5.98 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 11 stocks
  • Additional Purchases 57 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 71 stocks
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.